These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 14505244)

  • 21. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety.
    Winner P; Gendolla A; Stayer C; Wang S; Yuen E; Battisti WP; Nye JS
    Headache; 2006; 46(10):1503-10. PubMed ID: 17115983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topiramate in migraine prevention: results of a large controlled trial.
    Silberstein SD; Neto W; Schmitt J; Jacobs D;
    Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preventive treatment with topiramate enhances the quality of life of patients with migraine].
    Medrano V; Sempere AP; Morera-Guitart J; Fernandez-Izquierdo S; Espinosa-Martinez J
    Rev Neurol; 2006 Sep 1-15; 43(5):259-63. PubMed ID: 16941422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of episodic migraine with topiramate: a prospective 24-week, open-label, flexible-dose clinical trial with optional 24 weeks follow-up in a community setting.
    Malessa R; Gendolla A; Steinberg B; Schmitt L; Bornhoevd K; Djelani M; Schäuble B;
    Curr Med Res Opin; 2010 May; 26(5):1119-29. PubMed ID: 20225996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial.
    Mohammadianinejad SE; Abbasi V; Sajedi SA; Majdinasab N; Abdollahi F; Hajmanouchehri R; Faraji A
    Clin Neuropharmacol; 2011; 34(4):174-7. PubMed ID: 21738025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of topiramate and valproate in chronic migraine.
    Bartolini M; Silvestrini M; Taffi R; Lanciotti C; Luconi R; Capecci M; Provinciali L
    Clin Neuropharmacol; 2005; 28(6):277-9. PubMed ID: 16340383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topiramate: a case series study in migraine prophylaxis.
    Young WB; Hopkins MM; Shechter AL; Silberstein SD
    Cephalalgia; 2002 Oct; 22(8):659-63. PubMed ID: 12383061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
    Mei D; Ferraro D; Zelano G; Capuano A; Vollono C; Gabriele C; Di Trapani G
    Clin Neuropharmacol; 2006; 29(5):269-75. PubMed ID: 16960472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
    Cady RK; Voirin J; Farmer K; Browning R; Beach ME; Tarrasch J
    Headache; 2012 May; 52(5):749-64. PubMed ID: 22188311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP; Cady RK
    Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topiramate in migraine prophylaxis: data from a pooled analysis and open-label extension study.
    Bussone G; Usai S; D'Amico D
    Neurol Sci; 2006 May; 27 Suppl 2():S159-63. PubMed ID: 16688622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine.
    Keskinbora K; Aydinli I
    Clin Neurol Neurosurg; 2008 Dec; 110(10):979-84. PubMed ID: 18620801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of topiramate (topamax) in a subgroup of migraine-vertigo patients with auditory symptoms.
    Carmona S; Settecase N
    Ann N Y Acad Sci; 2005 Apr; 1039():517-20. PubMed ID: 15827012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-minimization analysis comparing topiramate with standard treatments in migraine prophylaxis.
    Ergun H; Gulmez SE; Tulunay FC
    Eur Neurol; 2007; 58(4):215-7. PubMed ID: 17827966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study.
    Shaygannejad V; Janghorbani M; Ghorbani A; Ashtary F; Zakizade N; Nasr V
    Headache; 2006 Apr; 46(4):642-8. PubMed ID: 16643559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zonisamide for migraine prophylaxis in patients refractory to topiramate.
    Bermejo PE; Dorado R
    Clin Neuropharmacol; 2009; 32(2):103-6. PubMed ID: 18978487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of the neuromodulators in the preventive treatment of migraine].
    Pascual-Gómez J
    Rev Neurol; 2009 Jul 1-15; 49(1):25-32. PubMed ID: 19557697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of levetiracetam vs topiramate and placebo on visually evoked phase synchronization changes of alpha rhythm in migraine.
    de Tommaso M; Marinazzo D; Nitti L; Pellicoro M; Guido M; Serpino C; Stramaglia S
    Clin Neurophysiol; 2007 Oct; 118(10):2297-304. PubMed ID: 17709295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of migraine on daily activities: effect of topiramate compared with placebo.
    Silberstein SD; Loder E; Forde G; Papadopoulos G; Fairclough D; Greenberg S
    Curr Med Res Opin; 2006 Jun; 22(6):1021-9. PubMed ID: 16846536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose topiramate plus sodium divalproate for positive responders intolerant to full-dose monotherapy.
    Krymchantowski AV; Jevoux Cda C
    Headache; 2012 Jan; 52(1):129-32. PubMed ID: 22085390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.